• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福平酶诱导作用导致西酞普兰浓度降低:一例报告

Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report.

作者信息

Liu Jiajia, Li Jinmeng, Zheng Ren, Zhang Ruoying

机构信息

Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang Province, China.

XiaoShan HangZhou Orthopedics TCM Hospital, Hangzhou, Zhejiang Province, China.

出版信息

Ther Adv Psychopharmacol. 2025 Mar 24;15:20451253251328582. doi: 10.1177/20451253251328582. eCollection 2025.

DOI:10.1177/20451253251328582
PMID:40151469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11946286/
Abstract

Citalopram is a selective serotonin reuptake inhibitor used to treat depression and various anxiety disorders, which is mainly metabolized by the P450 (CYP) enzyme. Rifampin is a rifamycin with bactericidal activity against . Rifampin significantly induces the P450 (CYP) enzyme system, which makes it susceptible to potential drug interactions with other medications. However, there have been few reports on the possible interaction between rifampin and citalopram. We report a 76-year-old patient who had been taking citalopram 20 mg daily for long-term treatment of depression. After 2 months of rifampin treatment for tuberculosis, the patient presented with intractable depressive symptoms, insomnia, and a profound sense of hopelessness. The trough plasma concentration of citalopram was monitored, which was 8.19 ng/mL, and failed to reach the guideline-recommended effective therapeutic range (50-110 ng/mL). Based on the therapeutic drug monitoring results of citalopram, the dosage of citalopram was adjusted to 40 mg daily, resulting in a significant improvement in depressive symptoms. This case provides further evidence of a clinically significant interaction that may occur between rifampin and citalopram.

摘要

西酞普兰是一种用于治疗抑郁症和各种焦虑症的选择性5-羟色胺再摄取抑制剂,主要通过P450(CYP)酶代谢。利福平是一种对……具有杀菌活性的利福霉素。利福平可显著诱导P450(CYP)酶系统,这使其易于与其他药物发生潜在的药物相互作用。然而,关于利福平和西酞普兰之间可能的相互作用的报道很少。我们报告了一名76岁的患者,该患者长期每日服用20毫克西酞普兰治疗抑郁症。在接受利福平治疗肺结核2个月后,患者出现难治性抑郁症状、失眠和深深的绝望感。监测了西酞普兰的血药谷浓度,为8.19纳克/毫升,未达到指南推荐的有效治疗范围(50-110纳克/毫升)。根据西酞普兰的治疗药物监测结果,将西酞普兰的剂量调整为每日40毫克,抑郁症状得到显著改善。该病例进一步证明了利福平和西酞普兰之间可能发生具有临床意义的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90be/11946286/d2a7bb2b8323/10.1177_20451253251328582-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90be/11946286/d2a7bb2b8323/10.1177_20451253251328582-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90be/11946286/d2a7bb2b8323/10.1177_20451253251328582-fig1.jpg

相似文献

1
Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report.利福平酶诱导作用导致西酞普兰浓度降低:一例报告
Ther Adv Psychopharmacol. 2025 Mar 24;15:20451253251328582. doi: 10.1177/20451253251328582. eCollection 2025.
2
Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram.一名正在服用西酞普兰的患者在接受利福平治疗时惊恐障碍加重。
Pharmacotherapy. 2005 Mar;25(3):435-7. doi: 10.1592/phco.25.3.435.61591.
3
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.帕罗西汀:在治疗惊恐障碍中的药理学和治疗潜力的综述。
CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.
4
Other Antidepressants.其他抗抑郁药。
Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167.
5
Lopinavir/ritonavir: a review of its use in the management of HIV infection.洛匹那韦/利托那韦:其在HIV感染管理中的应用综述
Drugs. 2003;63(8):769-802. doi: 10.2165/00003495-200363080-00004.
6
Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.选择性5-羟色胺再摄取抑制剂与中枢神经系统药物的相互作用。证据的批判性综述。
Clin Pharmacokinet. 1997 Dec;33(6):454-71. doi: 10.2165/00003088-199733060-00004.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Therapeutic drug monitoring in the treatment of tuberculosis.结核病治疗中的治疗药物监测
Drugs. 2002;62(15):2169-83. doi: 10.2165/00003495-200262150-00001.
9
Citalopram in pregnancy and lactation.西酞普兰在妊娠和哺乳期的应用。
Clin Pharmacol Ther. 2002 Aug;72(2):184-91. doi: 10.1067/mcp.2002.126181.
10
Multiple drug interactions with cyclosporine in a heart transplant patient.一名心脏移植患者中与环孢素的多种药物相互作用。
Ann Pharmacother. 1995 Feb;29(2):127-31. doi: 10.1177/106002809502900204.

本文引用的文献

1
Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients - a study based on a cohort of 19,742 patients.在老年患者中常见的血清浓度下,艾司西酞普兰和西酞普兰的致心律失常作用 - 基于 19742 名患者队列的研究。
EBioMedicine. 2023 Sep;95:104779. doi: 10.1016/j.ebiom.2023.104779. Epub 2023 Aug 26.
2
Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review.迈向对抑郁症中舍曲林进行治疗药物监测?一项系统评价的见解。
Front Psychiatry. 2023 Apr 27;14:1144573. doi: 10.3389/fpsyt.2023.1144573. eCollection 2023.
3
Decreased serum voriconazole levels caused by hepatic enzyme induction after rifapentine discontinuation: a case report and literature review.
利福喷汀停药后肝酶诱导导致伏立康唑血清水平降低:病例报告及文献复习。
Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3714-3718. doi: 10.26355/eurrev_202304_32170.
4
Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression.运动作为治疗抑郁症状的药物?系统评价和荟萃分析及荟萃回归。
Br J Sports Med. 2023 Aug;57(16):1049-1057. doi: 10.1136/bjsports-2022-106282. Epub 2023 Feb 1.
5
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.使用咪达唑仑持续微量输注的群体药代动力学模型定量评估 CYP3A 的抑制、激活和诱导的时间过程。
Clin Pharmacokinet. 2022 Nov;61(11):1595-1607. doi: 10.1007/s40262-022-01175-6. Epub 2022 Oct 4.
6
A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD).一项关于比较西酞普兰与非典型抗精神病药物治疗痴呆行为和心理症状(BPSD)中激越症状的疗效和安全性的研究叙述性综述。
Pharmacy (Basel). 2022 Jun 6;10(3):61. doi: 10.3390/pharmacy10030061.
7
Risk factors and protective factors of depression in older people 65+. A systematic review.老年人(65+)抑郁的风险因素和保护因素。系统评价。
PLoS One. 2021 May 13;16(5):e0251326. doi: 10.1371/journal.pone.0251326. eCollection 2021.
8
Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report and Review of Literature.基因多态性对华法林-利福平相互作用的影响:一例病例报告及文献综述
Pharmgenomics Pers Med. 2021 Jan 26;14:149-156. doi: 10.2147/PGPM.S288918. eCollection 2021.
9
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.5-羟色胺转运体的选择性抑制在抑郁症治疗中的应用:舍曲林、氟西汀和西酞普兰。
Neuropsychopharmacol Hung. 2020 Mar;22(1):4-15.
10
Analytical methodologies for the enantiodetermination of citalopram and its metabolites.西酞普兰及其代谢物对映体拆分的分析方法。
Chirality. 2020 Jan;32(1):32-41. doi: 10.1002/chir.23139. Epub 2019 Nov 8.